An Improved, Rapid, and Sensitive LC‐MS/MS Method for Quantification of Nitisinone From Human Plasma

ABSTRACT Nitisinone (NTBC) has been the standard therapy for hereditary tyrosinemia type 1 (HT‐1) since the early 1990s and remains the only effective treatment. To ascertain its therapeutic levels, a rapid and sensitive liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method for NTBC quantification in plasma is crucial. Existing methods often employ gradient elution, longer run time with limited sensitivity and selectivity, highlighting the need for improvement and to develop an isocratic method with sensitive quantification of NTBC. A rapid and highly sensitive LC‐MS/MS method was developed with direct protein precipitation for NTBC in plasma. Isocratic separation was achieved on a Purospher Star C‐18 column (30 × 4 mm, 3 µm) using ultrapure water and acetonitrile (48:52; v/v) with 0.2% formic acid. Acquisition was performed in multiple reaction monitoring mode with the transitions: m / z 328.0→281.0 and 328.0→239.0 for NTBC and m / z 284.1→141.1 for probenecid (internal standard) in negative ion mode. The selectivity, linearity, sensitivity, accuracy, precision, and recovery of the developed method were validated as per US‐FDA guidelines for bioanalytical method validation. The developed method demonstrated linearity over a concentration range of 1.56–400 ng/mL (4.73–1210 nM), with a coefficient of determination r 2 = 0.9991. For NTBC validation, the intra‐day precision (%CV) ranged from 1.82% to 11.07%, with accuracy between 93.20% and 107.81%, while the inter‐day precision (%CV) varied from 1.91% to 12.65%, with accuracy spanning from 89.19% to 112.83%. The method exhibited high sensitivity, with a limit of detection (LOD) of 0.76 nM (0.25 ng/mL) and a lower limit of quantification (LLOQ) of 1.18 nM (0.39 ng/mL). A highly sensitive LC‐MS/MS method for NTBC quantification from human plasma was developed and validated, incorporating significant improvements in analytical performance, including reduced run time with enhanced sensitivity and selectivity.

Authors

Institutions

Publication Details

Journal
Separation Science Plus
Published
2025-10-01
DOI
https://doi.org/10.1002/sscp.70136
Primary Topic
Nitric Oxide and Endothelin Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Improved, Rapid, and Sensitive LC‐MS/MS Method for Quantification of Nitisinone From Human Plasma

Thirumurthy Velpandian, Nabanita Halder, Neerja Gupta, Sudipto Das et al.
Separation Science Plus
Nitric Oxide and Endothelin Effects
article

An Improved, Rapid, and Sensitive LC‐MS/MS Method for Quantification of Nitisinone From Human Plasma

Thirumurthy Velpandian, Nabanita Halder, Neerja Gupta, Sudipto Das, Madhu Nath
article en

Abstract

ABSTRACT Nitisinone (NTBC) has been the standard therapy for hereditary tyrosinemia type 1 (HT‐1) since the early 1990s and remains the only effective treatment. To ascertain its therapeutic levels, a rapid and sensitive liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method for NTBC quantification in plasma is crucial. Existing methods often employ gradient elution, longer run time with limited sensitivity and selectivity, highlighting the need for improvement and to develop an isocratic method with sensitive quantification of NTBC. A rapid and highly sensitive LC‐MS/MS method was developed with direct protein precipitation for NTBC in plasma. Isocratic separation was achieved on a Purospher Star C‐18 column (30 × 4 mm, 3 µm) using ultrapure water and acetonitrile (48:52; v/v) with 0.2% formic acid. Acquisition was performed in multiple reaction monitoring mode with the transitions: m / z 328.0→281.0 and 328.0→239.0 for NTBC and m / z 284.1→141.1 for probenecid (internal standard) in negative ion mode. The selectivity, linearity, sensitivity, accuracy, precision, and recovery of the developed method were validated as per US‐FDA guidelines for bioanalytical method validation. The developed method demonstrated linearity over a concentration range of 1.56–400 ng/mL (4.73–1210 nM), with a coefficient of determination r 2 = 0.9991. For NTBC validation, the intra‐day precision (%CV) ranged from 1.82% to 11.07%, with accuracy between 93.20% and 107.81%, while the inter‐day precision (%CV) varied from 1.91% to 12.65%, with accuracy spanning from 89.19% to 112.83%. The method exhibited high sensitivity, with a limit of detection (LOD) of 0.76 nM (0.25 ng/mL) and a lower limit of quantification (LLOQ) of 1.18 nM (0.39 ng/mL). A highly sensitive LC‐MS/MS method for NTBC quantification from human plasma was developed and validated, incorporating significant improvements in analytical performance, including reduced run time with enhanced sensitivity and selectivity.

Separation Science PlusVol. 8(10)
All India Institute of Medical Sciences (IN)
Openalex Percentile: Top 65%
Nitric Oxide and Endothelin Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.